Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia

WHO, 1994 WHO, 2015, 1 Luciani, 2008, Interpreting genotype cluster sizes of Mycobacterium tuberculosis isolates typed with IS6110and spoligotyping, Infect. Genet. Evol., 8, 182, 10.1016/j.meegid.2007.12.004 WHO, 2017 Aziz, 2006, Epidemiology of antituberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis, Lancet, 368, 2142, 10.1016/S0140-6736(06)69863-2 Biadglegne, 2014, Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care, Antimicrob. Resist. Infect. Contr., 3, 31, 10.1186/2047-2994-3-31 Zignol, 2006, Global incidence of multidrug-resistant tuberculosis, J. Infect. Dis., 194, 479, 10.1086/505877 Shah, 2007, Worldwide emergence of extensively drug-resistant tuberculosis (XDR TB): global survey of second-line drug resistance among Mycobacterium tuberculosis isolates, Emerg. Infect. Dis., 13, 380, 10.3201/eid1303.061400 Coll, 2005, Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona, Microb. Drug Resist., 11, 107, 10.1089/mdr.2005.11.107 Drobniewski, 2007, Clin. Microbiol. Infect., 13, 1144, 10.1111/j.1469-0691.2007.01813.x Iseman, 1993, Treatment of multidrug-resistant tuberculosis, N. Engl. J. Med., 329, 784, 10.1056/NEJM199309093291108 Van, 1997, Novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa, Int. J. Syst. Bacteriol., 47, 1200 Dye, 2005, Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally, J. Am. Med. Assoc., 293, 2767, 10.1001/jama.293.22.2767 Murray, 2005, Mycobacterium. Medical Microbiology, Tuberculosis control and elimination 2010-50: cure, care, and social development, Lancet, 375, 1814 Vander, 2009, Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics, Tuberculosis (Edinb), 89, 120, 10.1016/j.tube.2008.09.003 Melake, 2004, Pulmonary tuberculosis in collaboration with the Ethiopia public heal the training initiative, 15, 203 Udoh, 2009, Pathogenesis and morphology of tuberculosis, Benin J. Postgrad. Med., 5, 55 Kayser, 2005, Basic principles of microbiology and immunology medical microbiology, 22, 1 Sudre, 1992, Tuberculosis: a global overview of the situation today, Bull. World Health Organ., 70, 149 Vander, 2012, Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis, Eur. Respir. J., 39, 1511, 10.1183/09031936.00125711 Marais, 2010, Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action, Lancet, 375, 2179, 10.1016/S0140-6736(10)60554-5 Berhan, 2013, A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?, Ethiop. J. Health Sci., 23, 271 Hu, 2011, A major subgroup of Beijing family Mycobacterium tuberculosis is associated with multidrug resistance and increased transmissibility, Epidemiol. Infect., 139, 130, 10.1017/S0950268810000890 Esmael, 2014, Drug resistance pattern of M. tuberculosis in Eastern Amhara Regional state, Ethiopia, J. Microb. Biochem. Technol., 6, 075, 10.4172/1948-5948.1000125 Zhang, 2009, Mechanisms of drug resistance in M. tuberculosis, Int. J. Tubercul. Lung Dis., 13, 1320 Gutacker, 2006, Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites, J. Infect. Dis., 193, 121, 10.1086/498574 Zhang, 2000, Genetics of drug resistance in Mycobacterium tuberculosis, vol. 66, 235 Pym, 2002, Drug resistance and tuberculosis chemotherapy from concept to genomics, vol. 33, 355 Bártfai, 2001, Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay, J. Clin. Microbiol., 39, 3736, 10.1128/JCM.39.10.3736-3739.2001 WHO, 2003, 9 Biadglegne, 2013, Tuberculous lymphadenitis in northern Ethiopia: in a public health and microbiological perspectives, PLoS One, 8, 10.1371/journal.pone.0081918 Ani, 2008, Advances in the laboratory diagnosis of M. tuberculosis, 7, 57 Abebe, 2011, Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings, J. Microbiol. Meth., 84, 155, 10.1016/j.mimet.2010.11.014 Torres, 2000, Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis, J. Clin. Microbiol., 38, 3194, 10.1128/JCM.38.9.3194-3199.2000 WHO, 2010 Park, 2009, Evaluation of an immunochromatographic assay kit for rapid identification of Mycobacterium tuberculosis complex in clinical isolates, J. Clin. Microbiol., 47, 481, 10.1128/JCM.01253-08 Tessema, 2012, First and second line anti-tuberculosis drug resistance in Northwest Ethiopia, Int. J. Tubercul. Lung Dis., 16, 805, 10.5588/ijtld.11.0522 Ling, 2008, Rapid diagnosis of drug resistant TB using line probe assays: from evidence to policy, Expet Rev. Respir. Med., 2, 583, 10.1586/17476348.2.5.583 Somoskovi, 2001, The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis, Respir. Res., 2, 164, 10.1186/rr54 Gegia, 2008, Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations, Antimicrob. Agents Chemother., 52, 725, 10.1128/AAC.01124-07 Troesch, 1999, Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays, J. Clin. Microbiol., 37, 49, 10.1128/JCM.37.1.49-55.1999 Vernet, 2004, Species differentiation and antibiotic susceptibility testing with DNA microarrays, J. Appl. Microbiol., 96, 59, 10.1046/j.1365-2672.2003.02116.x Yurong, 2011, Circulating MicroRNAs in patients with active pulmonary tuberculosis, J. Clin. Microbiol., 49, 4246, 10.1128/JCM.05459-11 Wang, 2011, Comparative miRNA expression profiles in individuals with latent and active tuberculosis, PLoS One, 6 Golub, 2006, Delayed tuberculosis diagnosis and tuberculosis transmission, Int. J. Tubercul. Lung Dis., 10, 24 Sharbati, 2011, Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominis- suis infection, PLoS One, 6, 10.1371/journal.pone.0020258 Ma, 2011, The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon γ, Nat. Immunol., 12, 861, 10.1038/ni.2073 Xing, 2013, Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis, PLoS One, 8